[Secondary autoimmune syndrome and immunomodulating lymphotropic therapy in acute pancreatitis].
Immune status and condition of regional lymphoid tissue were studied in 28 patients with various forms of acute pancreatitis untreated with immunomodulating therapy and in 12 patients receiving combined therapy including lymphotropic regional therapy with T-activin. Acute pancreatitis patients were found to have aquired immunodeficiency, secondary autoimmune syndrome and reaction of toxic immune complexes the severity of which decreased under the action of T-activin therapy.
Zaĭrat'iants
O V
OV
Russian Medical Academy of Postgraduate Medical Education, 129995, Moscow.
Kolobov
S V
SV
Iarema
I V
IV
Shevchenko
V P
VP
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001327:Autoimmune Diseases / Q000209:etiology / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology; D004386:Duodenum / Q000276:immunology / Q000473:pathology; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology; D008875:Middle Aged; D010179:Pancreas / Q000276:immunology / Q000473:pathology*; D019283:Pancreatitis, Acute Necrotizing / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D010455:Peptides / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000276:immunology; D013949:Thymus Extracts / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D007136:Immunoglobulins; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin